Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.
NCT ID: NCT00314652
Last Updated: 2006-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
260 participants
INTERVENTIONAL
1999-06-30
1999-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Buprenorphine transdermal delivery system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* receiving opioid therapy for osteoarthritis-related pain within the past year or have experienced pain that was inadequately controlled with a full standard dose of NSAIDs.
Exclusion Criteria
* scheduled to have surgery (including dental) during the study period that involved the use of pre- and/or postoperative analgesics or anesthetics.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Purdue Pharma LP
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hawthorne & York, International, Ltd.
Phoenix, Arizona, United States
Arizona Research Center, LLC
Phoenix, Arizona, United States
ACRC/Arizona Clinical Research
Tucson, Arizona, United States
Advanced Clinical Therapeutics
Tucson, Arizona, United States
San Diego Arthritis and Osteoporosis Research
San Diego, California, United States
Scripps Clinic Rancho Bernardo
San Diego, California, United States
Clinical Research Consultants, Inc.
Trumbull, Connecticut, United States
Tampa Bay Medical Research, Inc.
Clearwater, Florida, United States
University Clinical Research
DeLand, Florida, United States
Gainesville Clinical Research Center
Gainesville, Florida, United States
Physicians Research Associates Jacksonville
Jacksonville, Florida, United States
University Clinical Research, Inc.
Pembroke Pines, Florida, United States
Gold Coast Research, Inc.
Weston, Florida, United States
MediSphere Medical Research Center, LLC
Evansville, Indiana, United States
Westside Family Medical Center
Kalamazoo, Michigan, United States
Center for Pharmaceutical Research
Kansas City, Missouri, United States
NJP Clinical Research
Passaic, New Jersey, United States
PW Clinical Research, LLC
Winston-Salem, North Carolina, United States
New Century Research Center, Ltd.
Beaverbrook, Ohio, United States
Altoona Center for Clinical Research
Duncansville, Pennsylvania, United States
Mid-South Clinical Research Institute
Memphis, Tennessee, United States
Advanced Clinical Research
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BP99-0203
Identifier Type: -
Identifier Source: org_study_id